Regulation of aldo-keto reductases in human diseases

Frontiers in Pharmacology

Volumn 3 MAR, Issue , 2012, Pages

  Chen, Wei Dong ^a   Zhang, Yanqiao ^a  

^a Northeast Ohio Medical University   (United States)

Author keywords

Aldo keto reductase; Human disease; Regulation; Response element; Transcription factor

Indexed keywords

AFLATOXIN ALDEHYDE REDUCTASE; ALDEHYDE REDUCTASE; ALDO KETO REDUCTASE; ALDO KETO REDUCTASE FAMILY1; CHLORDECONE REDUCTASE; DELTA 4 3 KETOSTEROID 5 BETA REDUCTASE; DIHYDRODIOL DEHYDROGENASE 1; DIHYDRODIOL DEHYDROGENASE 2; OXIDOREDUCTASE; SHAKER CHANNEL BETA SUBUNIT; UNCLASSIFIED DRUG;

AKR1B1 GENE; AKR1C3 GENE; ARTICLE; ATHEROSCLEROSIS; BREAST CANCER; BREAST TUMOR; CHOLESTASIS; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; DIABETES MELLITUS; ENDOMETRIOSIS; ENZYME REGULATION; ENZYME SPECIFICITY; EPILEPSY; GENE; GENE EXPRESSION; HEPATITIS; HUMAN; LEARNING DISORDER; LEUKEMIA; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TUMOR; LUNG TUMOR; MEMORY DISORDER; PATHOGENESIS; PROSTATE CANCER; SEPSIS; TOXIC HEPATITIS; TRANSCRIPTION REGULATION; UVEITIS;

EID: 84865982067     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00035     Document Type: Article

References (63)

1. Abedin, Z., Sen, S., and Field, J. (2012). Aldo-keto reductases pro-tect lung adenocarcinoma cells from the acute toxicity of B[a]P-7,8-trans-dihydrodiol. Chem. Res. Toxicol. 25, 113-121.
2. Ahmed, M. M., Wang, T., Luo, Y., Ye, S., Wu, Q., Guo, Z., Roebuck, B. D., Sut-ter, T. R., andYang, J.Y. (2011). Aldo-keto reductase-7A protects liver cells and tissues from acetaminophen-induced oxidative stress and hepato-toxicity. Hepatology 54, 1322-1332.
3. Barski, O. A., Papusha, V. Z., Kunkel, G. R., and Gabbay, K. H. (2004). Regu-lation of aldehyde reductase expres-sion by STAF and CHOP. Genomics 83, 119-129.
4. Barski, O. A., Tipparaju, S. M., and Bhatnagar, A. (2008). The aldo-keto reductase superfamily and its role in drug metabolism and detox-ification. Drug Metab. Rev. 40, 553-624.
5. Birtwistle, J., Hayden, R. E., Khanim, F. L., Green, R. M., Pearce, C., Davies, N. J., Wake, N., Schrewe, H., Ride, J. P., Chipman, J. K., and Bunce, C. M. (2009). The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesis. Mutat. Res. 662, 67-74.
6. Burczynski, M. E., Lin, H. K., and Penning, T. M. (1999). Isoform-specific induction of a human aldo-keto reductase by polycyclic aro-matic hydrocarbons (PAHs), elec-trophiles,and oxidative stress: impli-cations for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res. 59, 607-614.
7. Busolin, G., Malacrida, S., Bisulli, F., Striano, P., Di Bonaventura, C., Egeo, G., Pasini, E., Cianci, V., Ferlazzo, E., Bianchi, A., Coppola, G., Elia, M., Mecarelli, O., Gobbi, G., Casellato, S., Marchini, M., Binelli, S., Freri, E., Granata, T., Posar, A., Parmeggiani, A., Vigliano, P., Boniver, C., Aguglia, U., Striano, S., Tinuper, P., Giallonardo, A. T., Michelucci, R., and Nobile, C. (2011). Association of intronic variants of the KCNAB1 gene with lateral temporal epilepsy. Epilepsy Res. 94, 110-116.
8. Charbonneau, A., and The, V. L. (2001). Genomic organization of a human 5beta-reductase and its pseudogene and substrate selec-tivity of the expressed enzyme. Biochim. Biophys. Acta 1517, 228-235.
9. Chen, Y. J., Yuan, C. C., Chow, K. C., Wang, P. H., Lai, C. R., Yen, M. S., and Wang, L. S. (2005). Overexpres-sion of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients. Gynecol. Oncol. 97, 110-117.
10. Chun, J. Y., Nadiminty, N., Dutt, S., Lou, W., Yang, J. C., Kung, H. J., Evans, C. P., and Gao, A. C. (2009). Interleukin-6 regulates androgen synthesis in prostate cancer cells. Clin. Cancer Res. 15, 4815-4822.
11. Clayton, P. T. (2011). Disorders of bile acid synthesis. J. Inherit. Metab. Dis. 34, 593-604.
12. Deng, H. B., Adikari, M., Parekh, H. K., and Simpkins, H. (2004). Ubiquitous induction of resis-tance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells over-expressing isoforms 1 and 2 of dihydrodiol dehydrogenase. Can-cer Chemother. Pharmacol. 54, 301-307.
13. Deng, H. B., Parekh, H. K., Chow, K. C., and Simpkins, H. (2002). Increased expression of dihydrodiol dehydro-genase induces resistance to cisplatin in human ovarian carcinoma cells. J. Biol. Chem. 277, 15035-15043.
14. Diez-Dacal, B., Gayarre, J., Gharbi, S., Timms, J. F., Coderch, C., Gago, F., and Perez-Sala, D. (2011). Identification of aldo-keto reduc-tase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity. Cancer Res. 71, 4161-4171.
15. Ebert, B., Kisiela, M., Wsol, V., and Maser, E. (2011). Protea-some inhibitors MG-132 and borte-zomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29. Chem. Biol. Interact. 191, 239-249.
16. Fantozzi, I., Platoshyn, O., Wong, A. H., Zhang, S., Remillard, C. V., Fur-tado, M. R., Petrauskene, O. V., and Yuan, J. X. (2006). Bone mor-phogenetic protein-2 upregulates expression and function of voltage-gated K+ channels in human pul-monary artery smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 291, L993-L1004.
17. Fung, K. M., Samara, E. N., Wong, C., Metwalli, A., Krlin, R., Bane, B., Liu, C. Z., Yang, J. T., Pitha, J. V., Culkin, D. J., Kropp, B. P., Penning, T. M., and Lin, H. K. (2006). Increased expression of type 2 3alpha-hydroxysteroid dehydroge-nase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma. Endocr. Relat. Cancer 13, 169-180.
18. Ge, X., Yin, L., Ma, H., Li, T., Chiang, J. Y., and Zhang, Y. (2011). Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glu-cose homeostasis. J. Lipid Res. 52, 1561-1568.
19. Gonzales, E., Cresteil, D., Baussan, C., Dabadie, A., Gerhardt, M. F., and Jacquemin, E. (2004). SRD5B1 (AKR1D1) gene analysis in delta(4)-3-oxosteroid 5beta-reductase defi-ciency: evidence for primary genetic defect. J. Hepatol. 40, 716-718.
20. Grip, O., Janciauskiene, S., and Lind-gren, S. (2002). Atorvastatin acti-vates PPAR-gamma and attenu-ates the inflammatory response in human monocytes. Inflamm. Res. 51, 58-62.
21. Hevir, N., Vouk, K., Sinkovec, J., Ribic-Pucelj, M., and Rizner, T. L. (2011). Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metab-olism in ovarian endometriosis. Chem. Biol. Interact. 191, 217-226.
22. Hsu, N. Y., Ho, H. C., Chow, K. C., Lin, T. Y., Shih, C. S., Wang, L. S., and Tsai, C. M. (2001). Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res. 61, 2727-2731.
23. Hung, J. J., Chow, K. C., Wang, H. W., and Wang, L. S. (2006). Expression of dihydrodiol dehydro-genase and resistance to chemother-apy and radiotherapy in adenocarci-noma cells of lung. Anticancer Res. 26, 2949-2955.
24. Jez, J. M., Bennett, M. J., Schlegel, B. P., Lewis, M., and Penning, T. M. (1997a). Comparative anatomy of the aldo-keto reductase superfamily. Biochem. J. 326(Pt 3), 625-636.
25. Jez, J. M., Flynn, T. G., and Penning, T. M. (1997b). A new nomenclature for the aldo-keto reductase super-family. Biochem. Pharmacol. 54, 639-647.
26. Jiang, T., Qu, J. J., Nishinaka, T., and Zhang, N. (2008). Transcription factor AP-1 regulates TGF-beta(1)-induced expression of aldose reduc-tase in cultured human mesan-gial cells. Nephrology (Carlton) 13, 212-217.
27. Jin, Y., Mesaros, A. C., Blair, I. A., and Penning, T. M. (2011). Stereospecific reduction of 5beta-reduced steroids by human ketos-teroid reductases of the AKR (aldo-keto reductase) superfamily: role of AKR1C1-AKR1C4 in the metabo-lism of testosterone and proges-terone via the 5beta-reductase path-way. Biochem. J. 437, 53-61.
28. Jin, Y., and Penning, T. M. (2007). Aldo-keto reductases and bioactiva-tion/detoxification. Annu.Rev.Phar-macol. Toxicol. 47, 263-292.
29. Ko, B. C., Ruepp, B., Bohren, K. M., Gabbay, K. H., and Chung, S. S. (1997). Identification and character-ization of multiple osmotic response sequences in the human aldose reductase gene. J. Biol. Chem. 272, 16431-16437.
30. Kropotova, E. S., Tychko, R. A., Zinov'Eva, O. L., Zyrianova, A. F., Khankin, S. L., Cherkes, V. L., Aliev, V. A., Beresten, S. F., Oparina, N., and Mashkova, T. D. (2010). Down-regulation of AKR1B10 gene expres-sion in colorectal cancer. Mol. Biol. (Mosk.) 44, 243-250.
31. Lee,Y.J.,Lee,G.J.,Baek,B.J.,Heo,S. H., Won, S. Y., Im, J. H., Cho, M. K., Nam, H. S., and Lee, S. H. (2011). Cadmium-induced up-regulation of aldo-keto reductase 1C3 expres-sion in human nasal septum car-cinoma RPMI-2650 cells: involve-ment of reactive oxygen species and phosphatidylinositol 3-kinase/Akt. Environ. Toxicol. Pharmacol. 31, 469-478.
32. Lefrancois-Martinez, A. M., Bertherat, J., Val, P., Tournaire, C., Gallo-Payet, N., Hyndman, D., Veyssiere, G., Bertagna, X., Jean, C., and Martinez, A. (2004). Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors. J. Clin. Endocrinol. Metab. 89, 3010-3019.
33. Lemonde, H. A., Custard, E. J., Bouquet, J., Duran, M., Overmars, H., Scam-bler, P. J., and Clayton, P. T. (2003). Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy. Gut 52, 1494-1499.
34. Liao, C. S., Tai, P. J., Huang, Y. H., Chen, R. N., Wu, S. M., Kuo, L. W., Yeh, C. T., Tsai, M. M., Chen, W. J., and Lin, K. H. (2009). Regulation of AKR1B1 by thyroid hormone and its receptors. Mol. Cell. Endocrinol. 307, 109-117.
35. Liu, J., Wen, G., and Cao, D. (2009a). Aldo-keto reductase fam-ily 1 member B1 inhibitors: old drugs with new perspectives. Recent Pat. Anticancer Drug. Discov. 4, 246-253.
36. Liu, M. J., Takahashi, Y., Wada, T., He, J., Gao, J., Tian, Y., Li, S., and Xie, W. (2009b). The aldo-keto reductase Akr1b7 gene is a common transcrip-tional target of xenobiotic recep-tors pregnane X receptor and con-stitutive and rostane receptor. Mol. Pharmacol. 76, 604-611.
37. Lou, H., Du, S., Ji, Q., and Stolz, A. (2006). Induction of AKR1C2 by phase II inducers: identifica-tion of a distal consensus antiox-idant response element regulated by NRF2. Mol. Pharmacol. 69, 1662-1672.
38. Mahadevan, D., DiMento, J., Croce, K. D., Riley, C., George, B., Fuchs, D., Mathews, T., Wilson, C., and Lobell, M. (2006). Transcriptosome and serum cytokine profiling of an atypical case of myelodysplas-tic syndrome with progression to acute myelogenous leukemia. Am. J. Hematol. 81, 779-786.
39. Mode, A., and Rafter, I. (1985). The sexually differentiated delta 4-3-ketosteroid 5 beta-reductase of rat liver. Purification, characterization, and quantitation. J. Biol. Chem. 260, 7137-7141.
40. Myslinski, E., Gerard, M. A., Krol, A., and Carbon, P. (2006). A genome scale location analysis of human Staf/ZNF143-binding sites suggests a widespread role for human Staf/ZNF143 in mammalian promoters. J. Biol. Chem. 281, 39953-39962.
41. Nishinaka, T., Miura, T., Okumura, M., Nakao, F., Nakamura, H., and Terada, T. (2011). Regulation of aldo-keto reductase AKR1B10 gene expression: involvement of tran-scription factor Nrf2. Chem. Biol. Interact. 191, 185-191.
42. Pallai, R., Simpkins, H., Chen, J., and Parekh, H. K. (2010). The CCAAT box binding transcription factor, nuclear factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) gene. Gene 459, 11-23.
43. Peng, X. C., Gong, F. M., Wei, M., Chen, X., Chen, Y., Cheng, K., Gao, F., Xu, F., Bi, F., and Liu, J. Y. (2010). Pro-teomic analysis of cell lines to iden-tify the irinotecan resistance pro-teins. J. Biosci. 35, 557-564.
44. Penning, T. M. (2005). AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers. Clin. Cancer Res. 11, 1687-1690.
45. Penning, T. M., and Byrns, M. C. (2009). Steroid hormone transforming aldo-keto reductases and cancer. Ann. N. Y. Acad. Sci. 1155, 33-42.
46. Penning, T. M., and Drury, J. E. (2007). Human aldo-keto reductases: func-tion, gene regulation, and single nucleotide polymorphisms. Arch. Biochem. Biophys. 464, 241-250.
47. Perkowski, J. J., and Murphy, G. G. (2011). Deletion of the mouse homolog of KCNAB2, a gene linked to monosomy 1p36, results in asso-ciative memory impairments and amygdala hyperexcitability. J. Neu-rosci. 31, 46-54.
48. Ramana, K. V. (2011). Aldose reduc-tase: new insights for an old enzyme. Biomol. Concepts 2, 103-114.
49. Roberson, A. E., Hyatt, K., Kenkel, C., Hanson, K., and Myers, D. A. (2011). Interleukin 1beta regulates proges-terone metabolism in human cer-vical fibroblasts. Reprod. Sci. doi: 10.1177/1933719111419246
50. Ruf, T. F., Quintes, S., Sternik, P., and Gottmann, U. (2009). Atorvastatin reduces the expression of aldo-keto reductases in HUVEC and PTEC. A new approach to influence the polyol pathway. Clin. Invest. Med. 32, E219-E228.
51. Schmidt,D. R.,Schmidt,S.,Holmstrom, S. R., Makishima, M.,Yu, R. T., Cum-mins, C. L., Mangelsdorf, D. J., and Kliewer, S. A. (2011). AKR1B7 is induced by the farnesoid X recep-tor and metabolizes bile acids. J. Biol. Chem. 286, 2425-2432.
52. Selga, E., Noe, V., and Ciudad, C. J. (2008). Transcriptional regulation of aldo-keto reductase 1C1 in HT29 human colon cancer cells resistant to methotrexate: role in the cell cycle and apoptosis. Biochem. Pharmacol. 75, 414-426.
53. Seo, H. G., Nishinaka, T., and Yabe-Nishimura, C. (2000). Nitric oxide up-regulates aldose reductase expression in rat vascular smooth muscle cells: a potential role for aldose reductase in vascular remodeling. Mol. Pharmacol. 57, 709-717.
54. Shoeb, M., Yadav, U. C., Srivastava, S. K., and Ramana, K. V. (2011). Inhibition of aldose reductase pre-vents endotoxin-induced inflam-mation by regulating the arachi-donic acid pathway in murine macrophages. Free Radic. Biol. Med. 51, 1686-1696.
55. Smuc, T., Hevir, N., Ribic-Pucelj, M., Husen, B., Thole, H., and Rizner, T. L. (2009). Disturbed estrogen and progesterone action in ovarian endometriosis. Mol. Cell. Endocrinol. 301, 59-64.
56. Stanbrough, M., Bubley, G. J., Ross, K., Golub, T. R., Rubin, M. A., Penning, T. M., Febbo, P. G., and Balk, S. P. (2006). Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res. 66, 2815-2825.
57. Stayrook, K. R., Rogers, P. M., Savkur, R. S., Wang, Y., Su, C., Varga, G., Bu, X., Wei, T., Nagpal, S., Liu, X. S., and Burris, T. P. (2008). Regulation of human 3 alpha-hydroxysteroid dehydrogenase (AKR1C4) expres-sion by the liver X receptor alpha. Mol. Pharmacol. 73, 607-612.
58. Volle, D. H., Repa, J. J., Mazur, A., Cummins, C. L., Val, P., Henry-Berger, J., Caira, F., Veyssiere, G., Mangelsdorf, D. J., and Lobaccaro, J. M. (2004). Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxifica-tion processes. Mol. Endocrinol. 18, 888-898.
59. Wakasaya,Y., Kawarabayashi, T., Watan-abe, M., Yamamoto-Watanabe, Y., Takamura, A., Kurata, T., Murakami, T.,Abe,K.,Yamada,K.,Wakabayashi, K., Sasaki, A., Westaway, D., Hyslop, P. S., Matsubara, E., and Shoji, M. (2011). Factors responsible for neu-rofibrillary tangles and neuronal cell losses in tauopathy. J. Neurosci. Res. 89, 576-584.
60. Wang, R., Wang, G., Ricard, M. J., Fer-ris, B., Strulovici-Barel, Y., Salit, J., Hackett, N. R., Gudas, L. J., and Crystal, R. G. (2010). Smoking-induced upregulation of AKR1B10 expression in the airway epithelium of healthy individuals. Chest 138, 1402-1410.
61. Yabe-Nishimura, C., Nishinaka, T., Iwata, K., and Seo, H. G. (2003). Up-regulation of aldose reductase by the substrate,methylglyoxal. Chem. Biol. Interact. 143-144, 317-323.
62. Yang, B., Hodgkinson, A. D., Oates, P. J., Kwon, H. M., Millward, B. A., and Demaine, A. G. (2006). Ele-vated activity of transcription factor nuclear factor of activated T-cells 5 (NFAT5) and diabetic nephropathy. Diabetes 55, 1450-1455.
63. Zhang, L., Lee, J. J., Tang, H., Fan, Y. H., Xiao, L., Ren, H., Kurie, J., Morice, R. C., Hong, W. K., and Mao, L. (2008). Impact of smoking cessa-tion on global gene expression in the bronchial epithelium of chronic smokers. Cancer Prev. Res. (Phila.) 1, 112-118.